InsidersTradesSigma
Total declarations
Companies
▲ Purchases (12 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
12
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+11.7%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by KUMAR AMIT, Chairman & CEO. Officer active across 2 companies, notably Anixa Biosciences Inc. In total, 15 filings have been published. Breakdown: 12 buys · 0 sell. Total volume traded: €463k. Activity tracked since 16 July 2021. The latest transaction was disclosed on 15 January 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations15 total
21,000 sharesCommon StockSEC:0001493152-26-028827:0
Ideal exit: 9 Mar 2027 (T+270)
43,000 shares@ US$2.234.2% of flowCommon StockSEC:0001493152-25-002321:0
Ideal exit: 12 Oct 2025 (T+270)
25,000 shares@ US$2.412.5% of flowCommon StockSEC:0001493152-24-023023:0
Ideal exit: 4 Mar 2025 (T+270)
30,000 shares@ US$3.224.0% of flowCommon StockSEC:0001493152-24-010028:0
Ideal exit: 10 Dec 2024 (T+270)
40,000 shares@ US$2.5754.3% of flowCommon StockSEC:0001493152-23-026125:0
640,000 shares@ US$2.57574.8% of flowCommon StockSEC:0001493152-22-026121:0
20,000 shares@ US$3.002.4% of flowCommon StockSEC:0001493152-22-000640
Ideal exit: 4 Oct 2022 (T+270)
20,000 shares@ US$3.000.056% mcap23.5% of flowCommon StockSEC:0001493152-22-000640:0
Ideal exit: 4 Oct 2022 (T+270)
2,000 shares@ US$4.770.0086% mcap3.6% of flowCommon StockSEC:0001493152-21-026828:0
Ideal exit: 26 Jul 2022 (T+270)
2,000 shares@ US$4.770.4% of flowCommon StockSEC:0001493152-21-026828
Ideal exit: 26 Jul 2022 (T+270)
5,000 shares@ US$4.280.8% of flowCommon StockSEC:0001493152-21-017833
Ideal exit: 19 Apr 2022 (T+270)
5,000 shares@ US$4.280.019% mcap8.1% of flowCommon StockSEC:0001493152-21-017833:0
Ideal exit: 19 Apr 2022 (T+270)
10,000 shares@ US$3.941.5% of flowCommon StockSEC:0001493152-21-017276
Ideal exit: 12 Apr 2022 (T+270)
10,000 shares@ US$3.940.035% mcap14.8% of flowCommon StockSEC:0001493152-21-017276:0
Ideal exit: 12 Apr 2022 (T+270)
200,000 sharesCommon StockSEC:0001209191-16-089321:0
15 of 15 declarations
About KUMAR AMIT
Amit Kumar is the Chief Executive Officer of Anixa Biosciences Inc. In this role, he is responsible for the strategic direction of the company and innovation in the biotechnology field. Under his leadership, Anixa Biosciences strives to develop innovative solutions to meet market needs. Amit Kumar works closely with his team to achieve the company's growth objectives.
